Apyx Medical Corp Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Apyx Medical Corp quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Apyx Medical Corp Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $16.4M, a 36.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $16.4M +$4.38M +36.3% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $12.1M +$5.1M +73.2% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $6.97M +$3.13M +81.6% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $3.84M -$2.64M -40.7% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $6.47M +$4.73M +272% Dec 31, 2019 10-K 2021-03-31
Q4 2018 $1.74M -$7.01M -80.1% Dec 31, 2018 10-K 2020-03-31
Q4 2017 $8.76M -$1.43M -14% Dec 31, 2017 10-K 2020-03-31
Q4 2016 $10.2M +$2.78M +37.6% Dec 31, 2016 10-K 2019-03-14
Q4 2015 $7.4M Dec 31, 2015 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.